Prognostic impact of stromal cell-derived urokinase-type plasminogen activator in gastric carcinoma

Cancer

Volumn 85, Issue 5, 1999, Pages 1033-1038

  Okusa, Yasushi ^a   Ichikura, Takashi ^a   Mochizuki, Hidetaka ^a  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

Author keywords

Enzymatic activity; Gastric carcinoma; Immunohistochemistry; Stromal cells; Urokinase type plasminogen activator

Indexed keywords

UROKINASE;

ARTICLE; BASEMENT MEMBRANE; CANCER INVASION; DIAGNOSTIC VALUE; ENZYME ACTIVITY; ENZYME ASSAY; EXTRACELLULAR MATRIX; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; METASTASIS POTENTIAL; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; STOMACH CARCINOMA;

HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; NEOPLASM INVASIVENESS; PLASMINOGEN ACTIVATORS; PROGNOSIS; STOMACH NEOPLASMS; STROMAL CELLS; SURVIVAL ANALYSIS; URINARY PLASMINOGEN ACTIVATOR;

EID: 0033045597     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19990301)85:5<1033::AID-CNCR4>3.0.CO;2-K     Document Type: Article

References (20)

1. Reilly D, Andreasen PA, Duffy MJ. Urokinase-plasminogen activator in breast cancer: assay by both catalytic and immunoassay. Blood Coagul Fibrinolysis 1991;2:47-50.
2. Duggan C, Maguire T, McDermott E, O'Higgins N, Fennelly JJ, Duffy MJ. Urokinase plasminogen activator and urokinase plasminogen activator receptor in breast cancer. Int J Cancer 1995;61:597-600.
3. Grondahl-Hansen J, Ralfkiaer E, Kirkeby LT, Kristensen P, Lund LR, Dano K. Localization of urokinase-type plasminogen activator in stromal cells in adenocarcinomas of the colon in humans. Am J Pathol 1991;138:111-7.
4. Miseljic S, Galandiuk S, Myers SD, Wittliff JL. Expression of urokinase-type plasminogen activator and plasminogen activator inhibitor in colon disease. J Clin Lab Anal 1995;9: 413-7.
5. Umehara Y, Kimura T, Yoshida M, Oba N, Harada Y. Relationship between plasminogen activators and stomach carcinoma stage. Acta Oncol 1991;30:815-8.
6. Heiss MM, Babic R, Allgayer H, Gruetzner KU, Jauch KW, Loehrs U, et al. The prognostic impact of the urokinase-type plasminogen activator system is associated with tumour differentiated in gastric cancer. Eur J Surg Oncol 1996;22: 74-7.
7. Cho JY, Chung HC, Noh SH, Roh JK, Min JS, Kim BS. High level of urokinase-type plasminogen activator is a new prognostic marker in patients with gastric carcinoma. Cancer 1997;79:878-83.
8. Kasai S, Arimura H, Nishida M, Suyama T. Primary structure of single-chain pro-urokinase. J Biol Chem 1985;260: 12382-9.
9. Petersen LC, Lund LR, Nielsen LS, Dano K, Skriver L. Onechain urokinase-type plasminogen activator from human sarcoma cells is a proenzyme with little or not intrinsic activity. J Biol Chem 1988;263:11189-95.
10. Harvey SR, Lawrence DD, Madeja JM, Abbey SJ, Markus G. Secretion of plasminogen activators by human colorectal and gastric tumor explants. Clin Exp Metastasis 1988;6:431-50.
11. Wilhelm O, Hafter R, Henschen A, Schmitt M, Graeff H. Role of plasmin in the degradation of the stroma-derived fibrin in human ovarian carcinoma. Blood 1990;75:1673-8.
12. Ellis V, Pyke C, Eriksen J, Solberg H, Dano K. The urokinase receptor: involvement in cell surface proteolysis and cancer invasion. Ann N Y Acad Sci 1992;667:13-31.
13. Keski-Oja J, Koli K. Enhanced production of plasminogen activator activity in human and murine keratinocytes by transforming growth factor-beta 1. J Invest Dermatol 1992; 99:193-200.
14. Naldini L, Tamagnone L, Vigna E, Sachs M, Hartmann G, Birchmeier W, et al. Extracellular proteolytic cleavage by urokinase is required for activation of hepatocyte growth factor/scatter factor. EMBO J 1992;11:4825-33.
15. Pyke C, Kristensen P, Ralfkiaer E, Grondahl HJ, Eriksen J, Blasi F, et al. Urokinase-type plasminogen activator is expressed in stromal cells and its receptor in cancer cells at invasive foci in human colon adenocarcinomas. Am J Pathol 1991;138:1059-67.
16. Pyke C, Kristensen P, Ralfkiaer E, Eriksen J, Dano K. The plasminogen activation system in human colon cancer: messenger RNA for the inhibitor PAI-1 is located in endothelial cells in the tumor stroma. Cancer Res 1991;51:4067-71.
17. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72: 248-54.
18. Hermanek P, Sobin LH, editors. UICC TNM classification of malignant tumors. 4th edition. 2nd revision. Berlin: Springer-Verlag, 1992.
19. Japanese Research Society for Gastric Cancer. Japanese classification of gastric carcinoma. 1st English edition. Tokyo: Kanehara & Co., 1995.
20. Morioka S, Lazarus GS, Baird JL, Jensen PJ. Migrating keratinocytes express urokinase-type plasminogen activator. J Invest Dermatol 1987;88:418-23.